Thriving Three Groups on LinkedIn | Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Feeds:: Posts; Comments

« Weill Cornell Medicine to Expand Tumor Exome Test (EXaCT-1 identifies alterations within tumors) to Thousands of Advanced Cancer Patients

Key Opinion Leader (KOL) in Pharmaceutical Business Intelligence – Aviva Lev-Ari, PhD, RN, as Evidenced by »

Thriving Three Groups on LinkedIn

July 20, 2016 by 2012pharmaceutical

Thriving Three Groups on LinkedIn

Reporter: Aviva Lev-Ari, PhD, RN

Article ID #206: Thriving Three Groups on LinkedIn. Published on 8/20/2016

WordCloud Image Produced by Adam Tubman

Groups Launcher and Group Manager: Aviva Lev-Ari, PhD, RN

Cardiovascular Biotech & Pharma UK & US Networking Group

https://www.linkedin.com/groups/4357927

Leaders in Pharmaceutical Business Intelligence

https://www.linkedin.com/groups/4346921

Innovation in Israel

https://www.linkedin.com/groups/2987122

Posted in 3D Printing for Medical Application, BioIT: BioInformatics, NGS, Clinical & Translational, Pharmaceutical R&D Informatics, Clinical Genomics, Cancer Informatics, BioTechnology - Venture Creation, Venture Capital, CANCER BIOLOGY & Innovations in Cancer Therapy, Cardiac and Cardiovascular Surgical Procedures, Cardiovascular Research, Computational Biology/Systems and Bioinformatics, CRISPR/Cas9 & Gene Editing, DNA repair, Drug Delivery Platform Technology, Epigenetics and Environmental Factors, FDA Regulatory Affairs, Frontiers in Cardiology and Cardiovascular Disorders, Genome Biology, Genomic Testing: Methodology for Diagnosis, Global Partnering & Biotech Investment, Health Law & Patient Safety, HealthCare IT, Human Immune System in Health and in Disease, Immuno-Oncology & Genomics, Immunodiagnostics, Intellectual Property, Innovations, Commercialization, Investment in technological breakthrough, International Global Work in Pharmaceutical, Interventional Oncology: Radiofrequency Ablation, Transarterial Chemoembolization, Microwave Ablation and Irreversible Electroporation (IRE), Interviews with Scientific Leaders, Investment in Technological Breakthrough, Medical Devices R&D and Inventions, Origins of Cardiovascular Disease, Pharmacotherapy of Cardiovascular Disease | Leave a Comment

Leave a ReplyCancel reply

%d